Candice Yip
Otolaryngology · Las Vegas, NVNPI 1396165171
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,629 of the $5,330 with a category attached, or 68.1%. 19 manufacturers reported payments, led by Stryker at 41.0% of the total.
Across 130 payments — averaging $41.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Inspire Medical Systems, Inc.$834
- Regeneron Healthcare Solutions, Inc.$643
- Sanofi$401
- Optinose US, Inc.$352
- GSK$248
- plus $668 from 13 others
What the payments were for
- Travel & lodging$1,06020%
- Food & beverage$3,62968%
- Education$64112%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 27 | $2,183 |
| Inspire Medical Systems, Inc. | 7 | $834 |
| Regeneron Healthcare Solutions, Inc. | 23 | $643 |
| Sanofi | 15 | $401 |
| Optinose US, Inc. | 26 | $352 |
| GSK | 13 | $248 |
| Smith+Nephew | 2 | $187 |
| Regeneron | 1 | $99 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Intersect ENT, Inc. | 4 | $67 |
| Acclarent, Inc | 1 | $40 |
| Medtronic | 2 | $38 |
| Covis Pharma GmbH | 2 | $29 |
| Hologic Sales And Service, LLC | 1 | $21 |
| Itamar Medical Inc | 1 | $20 |
| Merck | 1 | $20 |
| Amgen | 1 | $19 |
| 3-d Matrix, Inc. | 1 | $15 |
| Microline Surgical Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,330 in reported general payments places this provider in the 80th percentile of 41 otolaryngology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 149 | $4,805 |
| Fluticasone Propionate | 202 | $2,402 |
| Ipratropium Bromide | 95 | $2,120 |
| Montelukast Sodium | 79 | $716 |
| Omeprazole | 31 | $493 |
| Famotidine | 31 | $382 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 35 | $224 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $126 |
| Methylprednisolone | 16 | $91 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Las Vegas
- Oluwafunmilola OkuyemiLas Vegas$60K
- Jeannie KhavkinLas Vegas$22K
- Robert WangLas Vegas$9K
- Suparna ShahLas Vegas$8K
- Daniel HiltonLas Vegas$5K
- Steven BeckerLas Vegas$4K
- Harry ChingLas Vegas$4K
- Lenhanh TranLas Vegas$3K
- Phillip SayLas Vegas$2K
- Sean PalaciosLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.